Global Omalizumab Biologic Injection Supply, Demand and Key Producers, 2026-2032
The global Omalizumab Biologic Injection market size is expected to reach $ 129 million by 2032, rising at a market growth of 8.5% CAGR during the forecast period (2026-2032).
Omalizumab Biologic Injection is a monoclonal antibody drug targeting immunoglobulin E (IgE), mainly used for the treatment of allergic asthma, chronic spontaneous urticaria, nasal polyps, and other IgE-mediated diseases. It works by binding to free IgE in the blood, thereby reducing allergic reactions and inflammation. Upstream of the industry chain mainly includes biotechnology raw materials, cell culture media, recombinant protein expression systems, bioreactor equipment, and contract development and manufacturing organizations (CDMOs). Midstream consists of biopharmaceutical companies producing original biologics and biosimilars, formulation manufacturers, fill-finish providers, and cold chain logistics companies. Downstream includes hospitals, specialty clinics, retail pharmacies, online pharmacies, and patients suffering from severe allergic or autoimmune-related conditions. With the growing prevalence of allergic diseases and the expansion of biologic therapies, the market demand for Omalizumab Injection continues to increase globally.
This report studies the global Omalizumab Biologic Injection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Omalizumab Biologic Injection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Omalizumab Biologic Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Omalizumab Biologic Injection total market, 2021-2032, (USD Million)
Global Omalizumab Biologic Injection total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Omalizumab Biologic Injection total market, key domestic companies, and share, (USD Million)
Global Omalizumab Biologic Injection revenue by player, revenue and market share 2021-2026, (USD Million)
Global Omalizumab Biologic Injection total market by Type, CAGR, 2021-2032, (USD Million)
Global Omalizumab Biologic Injection total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Omalizumab Biologic Injection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Glenmark Pharmaceuticals, Selexis, Generium, CuraTeQ, Celltrion Healthcare, Alvotech, BiosanaPharma, Mabpharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Omalizumab Biologic Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Omalizumab Biologic Injection Market, By Region:
1. How big is the global Omalizumab Biologic Injection market?
2. What is the demand of the global Omalizumab Biologic Injection market?
3. What is the year over year growth of the global Omalizumab Biologic Injection market?
4. What is the total value of the global Omalizumab Biologic Injection market?
5. Who are the Major Players in the global Omalizumab Biologic Injection market?
6. What are the growth factors driving the market demand?
Omalizumab Biologic Injection is a monoclonal antibody drug targeting immunoglobulin E (IgE), mainly used for the treatment of allergic asthma, chronic spontaneous urticaria, nasal polyps, and other IgE-mediated diseases. It works by binding to free IgE in the blood, thereby reducing allergic reactions and inflammation. Upstream of the industry chain mainly includes biotechnology raw materials, cell culture media, recombinant protein expression systems, bioreactor equipment, and contract development and manufacturing organizations (CDMOs). Midstream consists of biopharmaceutical companies producing original biologics and biosimilars, formulation manufacturers, fill-finish providers, and cold chain logistics companies. Downstream includes hospitals, specialty clinics, retail pharmacies, online pharmacies, and patients suffering from severe allergic or autoimmune-related conditions. With the growing prevalence of allergic diseases and the expansion of biologic therapies, the market demand for Omalizumab Injection continues to increase globally.
This report studies the global Omalizumab Biologic Injection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Omalizumab Biologic Injection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Omalizumab Biologic Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Omalizumab Biologic Injection total market, 2021-2032, (USD Million)
Global Omalizumab Biologic Injection total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Omalizumab Biologic Injection total market, key domestic companies, and share, (USD Million)
Global Omalizumab Biologic Injection revenue by player, revenue and market share 2021-2026, (USD Million)
Global Omalizumab Biologic Injection total market by Type, CAGR, 2021-2032, (USD Million)
Global Omalizumab Biologic Injection total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Omalizumab Biologic Injection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Glenmark Pharmaceuticals, Selexis, Generium, CuraTeQ, Celltrion Healthcare, Alvotech, BiosanaPharma, Mabpharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Omalizumab Biologic Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Omalizumab Biologic Injection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 150 mg/mL
- 75 mg/0.5 mL
- For Adults
- For Teenagers
- For Children
- Hospital
- Clinic
- Others
- Roche
- Novartis
- Glenmark Pharmaceuticals
- Selexis
- Generium
- CuraTeQ
- Celltrion Healthcare
- Alvotech
- BiosanaPharma
- Mabpharm
- CSPC Pharmaceutical Group
- Biomabs
- HisunPharm
1. How big is the global Omalizumab Biologic Injection market?
2. What is the demand of the global Omalizumab Biologic Injection market?
3. What is the year over year growth of the global Omalizumab Biologic Injection market?
4. What is the total value of the global Omalizumab Biologic Injection market?
5. Who are the Major Players in the global Omalizumab Biologic Injection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Omalizumab Biologic Injection Introduction
1.2 World Omalizumab Biologic Injection Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Omalizumab Biologic Injection Total Market by Region (by Headquarter Location)
1.3.1 World Omalizumab Biologic Injection Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.3.3 China Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.3.4 Europe Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.3.5 Japan Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.3.6 South Korea Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.3.7 ASEAN Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.3.8 India Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Omalizumab Biologic Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Omalizumab Biologic Injection Consumption Value (2021-2032)
2.2 World Omalizumab Biologic Injection Consumption Value by Region
2.2.1 World Omalizumab Biologic Injection Consumption Value by Region (2021-2026)
2.2.2 World Omalizumab Biologic Injection Consumption Value Forecast by Region (2027-2032)
2.3 United States Omalizumab Biologic Injection Consumption Value (2021-2032)
2.4 China Omalizumab Biologic Injection Consumption Value (2021-2032)
2.5 Europe Omalizumab Biologic Injection Consumption Value (2021-2032)
2.6 Japan Omalizumab Biologic Injection Consumption Value (2021-2032)
2.7 South Korea Omalizumab Biologic Injection Consumption Value (2021-2032)
2.8 ASEAN Omalizumab Biologic Injection Consumption Value (2021-2032)
2.9 India Omalizumab Biologic Injection Consumption Value (2021-2032)
3 WORLD OMALIZUMAB BIOLOGIC INJECTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Omalizumab Biologic Injection Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Omalizumab Biologic Injection Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Omalizumab Biologic Injection in 2025
3.2.3 Global Concentration Ratios (CR8) for Omalizumab Biologic Injection in 2025
3.3 Omalizumab Biologic Injection Company Evaluation Quadrant
3.4 Omalizumab Biologic Injection Market: Overall Company Footprint Analysis
3.4.1 Omalizumab Biologic Injection Market: Region Footprint
3.4.2 Omalizumab Biologic Injection Market: Company Product Type Footprint
3.4.3 Omalizumab Biologic Injection Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Omalizumab Biologic Injection Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Omalizumab Biologic Injection Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Omalizumab Biologic Injection Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Omalizumab Biologic Injection Consumption Value Comparison
4.2.1 United States VS China: Omalizumab Biologic Injection Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Omalizumab Biologic Injection Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Omalizumab Biologic Injection Companies and Market Share, 2021-2026
4.3.1 United States Based Omalizumab Biologic Injection Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Omalizumab Biologic Injection Revenue, (2021-2026)
4.4 China Based Companies Omalizumab Biologic Injection Revenue and Market Share, 2021-2026
4.4.1 China Based Omalizumab Biologic Injection Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Omalizumab Biologic Injection Revenue, (2021-2026)
4.5 Rest of World Based Omalizumab Biologic Injection Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Omalizumab Biologic Injection Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Omalizumab Biologic Injection Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Omalizumab Biologic Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 150 mg/mL
5.2.2 75 mg/0.5 mL
5.3 Market Segment by Type
5.3.1 World Omalizumab Biologic Injection Market Size by Type (2021-2026)
5.3.2 World Omalizumab Biologic Injection Market Size by Type (2027-2032)
5.3.3 World Omalizumab Biologic Injection Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY AGE
6.1 World Omalizumab Biologic Injection Market Size Overview by Age: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Age
6.2.1 For Adults
6.2.2 For Teenagers
6.2.3 For Children
6.3 Market Segment by Age
6.3.1 World Omalizumab Biologic Injection Market Size by Age (2021-2026)
6.3.2 World Omalizumab Biologic Injection Market Size by Age (2027-2032)
6.3.3 World Omalizumab Biologic Injection Market Size Market Share by Age (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Omalizumab Biologic Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospital
7.2.2 Clinic
7.2.3 Others
7.3 Market Segment by Application
7.3.1 World Omalizumab Biologic Injection Market Size by Application (2021-2026)
7.3.2 World Omalizumab Biologic Injection Market Size by Application (2027-2032)
7.3.3 World Omalizumab Biologic Injection Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Roche
8.1.1 Roche Details
8.1.2 Roche Major Business
8.1.3 Roche Omalizumab Biologic Injection Product and Services
8.1.4 Roche Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Roche Recent Developments/Updates
8.1.6 Roche Competitive Strengths & Weaknesses
8.2 Novartis
8.2.1 Novartis Details
8.2.2 Novartis Major Business
8.2.3 Novartis Omalizumab Biologic Injection Product and Services
8.2.4 Novartis Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Novartis Recent Developments/Updates
8.2.6 Novartis Competitive Strengths & Weaknesses
8.3 Glenmark Pharmaceuticals
8.3.1 Glenmark Pharmaceuticals Details
8.3.2 Glenmark Pharmaceuticals Major Business
8.3.3 Glenmark Pharmaceuticals Omalizumab Biologic Injection Product and Services
8.3.4 Glenmark Pharmaceuticals Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
8.3.6 Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
8.4 Selexis
8.4.1 Selexis Details
8.4.2 Selexis Major Business
8.4.3 Selexis Omalizumab Biologic Injection Product and Services
8.4.4 Selexis Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 Selexis Recent Developments/Updates
8.4.6 Selexis Competitive Strengths & Weaknesses
8.5 Generium
8.5.1 Generium Details
8.5.2 Generium Major Business
8.5.3 Generium Omalizumab Biologic Injection Product and Services
8.5.4 Generium Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Generium Recent Developments/Updates
8.5.6 Generium Competitive Strengths & Weaknesses
8.6 CuraTeQ
8.6.1 CuraTeQ Details
8.6.2 CuraTeQ Major Business
8.6.3 CuraTeQ Omalizumab Biologic Injection Product and Services
8.6.4 CuraTeQ Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 CuraTeQ Recent Developments/Updates
8.6.6 CuraTeQ Competitive Strengths & Weaknesses
8.7 Celltrion Healthcare
8.7.1 Celltrion Healthcare Details
8.7.2 Celltrion Healthcare Major Business
8.7.3 Celltrion Healthcare Omalizumab Biologic Injection Product and Services
8.7.4 Celltrion Healthcare Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Celltrion Healthcare Recent Developments/Updates
8.7.6 Celltrion Healthcare Competitive Strengths & Weaknesses
8.8 Alvotech
8.8.1 Alvotech Details
8.8.2 Alvotech Major Business
8.8.3 Alvotech Omalizumab Biologic Injection Product and Services
8.8.4 Alvotech Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Alvotech Recent Developments/Updates
8.8.6 Alvotech Competitive Strengths & Weaknesses
8.9 BiosanaPharma
8.9.1 BiosanaPharma Details
8.9.2 BiosanaPharma Major Business
8.9.3 BiosanaPharma Omalizumab Biologic Injection Product and Services
8.9.4 BiosanaPharma Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 BiosanaPharma Recent Developments/Updates
8.9.6 BiosanaPharma Competitive Strengths & Weaknesses
8.10 Mabpharm
8.10.1 Mabpharm Details
8.10.2 Mabpharm Major Business
8.10.3 Mabpharm Omalizumab Biologic Injection Product and Services
8.10.4 Mabpharm Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Mabpharm Recent Developments/Updates
8.10.6 Mabpharm Competitive Strengths & Weaknesses
8.11 CSPC Pharmaceutical Group
8.11.1 CSPC Pharmaceutical Group Details
8.11.2 CSPC Pharmaceutical Group Major Business
8.11.3 CSPC Pharmaceutical Group Omalizumab Biologic Injection Product and Services
8.11.4 CSPC Pharmaceutical Group Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 CSPC Pharmaceutical Group Recent Developments/Updates
8.11.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
8.12 Biomabs
8.12.1 Biomabs Details
8.12.2 Biomabs Major Business
8.12.3 Biomabs Omalizumab Biologic Injection Product and Services
8.12.4 Biomabs Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 Biomabs Recent Developments/Updates
8.12.6 Biomabs Competitive Strengths & Weaknesses
8.13 HisunPharm
8.13.1 HisunPharm Details
8.13.2 HisunPharm Major Business
8.13.3 HisunPharm Omalizumab Biologic Injection Product and Services
8.13.4 HisunPharm Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 HisunPharm Recent Developments/Updates
8.13.6 HisunPharm Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Omalizumab Biologic Injection Industry Chain
9.2 Omalizumab Biologic Injection Upstream Analysis
9.3 Omalizumab Biologic Injection Midstream Analysis
9.4 Omalizumab Biologic Injection Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Omalizumab Biologic Injection Introduction
1.2 World Omalizumab Biologic Injection Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Omalizumab Biologic Injection Total Market by Region (by Headquarter Location)
1.3.1 World Omalizumab Biologic Injection Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.3.3 China Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.3.4 Europe Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.3.5 Japan Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.3.6 South Korea Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.3.7 ASEAN Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.3.8 India Based Company Omalizumab Biologic Injection Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Omalizumab Biologic Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Omalizumab Biologic Injection Consumption Value (2021-2032)
2.2 World Omalizumab Biologic Injection Consumption Value by Region
2.2.1 World Omalizumab Biologic Injection Consumption Value by Region (2021-2026)
2.2.2 World Omalizumab Biologic Injection Consumption Value Forecast by Region (2027-2032)
2.3 United States Omalizumab Biologic Injection Consumption Value (2021-2032)
2.4 China Omalizumab Biologic Injection Consumption Value (2021-2032)
2.5 Europe Omalizumab Biologic Injection Consumption Value (2021-2032)
2.6 Japan Omalizumab Biologic Injection Consumption Value (2021-2032)
2.7 South Korea Omalizumab Biologic Injection Consumption Value (2021-2032)
2.8 ASEAN Omalizumab Biologic Injection Consumption Value (2021-2032)
2.9 India Omalizumab Biologic Injection Consumption Value (2021-2032)
3 WORLD OMALIZUMAB BIOLOGIC INJECTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Omalizumab Biologic Injection Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Omalizumab Biologic Injection Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Omalizumab Biologic Injection in 2025
3.2.3 Global Concentration Ratios (CR8) for Omalizumab Biologic Injection in 2025
3.3 Omalizumab Biologic Injection Company Evaluation Quadrant
3.4 Omalizumab Biologic Injection Market: Overall Company Footprint Analysis
3.4.1 Omalizumab Biologic Injection Market: Region Footprint
3.4.2 Omalizumab Biologic Injection Market: Company Product Type Footprint
3.4.3 Omalizumab Biologic Injection Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Omalizumab Biologic Injection Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Omalizumab Biologic Injection Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Omalizumab Biologic Injection Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Omalizumab Biologic Injection Consumption Value Comparison
4.2.1 United States VS China: Omalizumab Biologic Injection Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Omalizumab Biologic Injection Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Omalizumab Biologic Injection Companies and Market Share, 2021-2026
4.3.1 United States Based Omalizumab Biologic Injection Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Omalizumab Biologic Injection Revenue, (2021-2026)
4.4 China Based Companies Omalizumab Biologic Injection Revenue and Market Share, 2021-2026
4.4.1 China Based Omalizumab Biologic Injection Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Omalizumab Biologic Injection Revenue, (2021-2026)
4.5 Rest of World Based Omalizumab Biologic Injection Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Omalizumab Biologic Injection Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Omalizumab Biologic Injection Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Omalizumab Biologic Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 150 mg/mL
5.2.2 75 mg/0.5 mL
5.3 Market Segment by Type
5.3.1 World Omalizumab Biologic Injection Market Size by Type (2021-2026)
5.3.2 World Omalizumab Biologic Injection Market Size by Type (2027-2032)
5.3.3 World Omalizumab Biologic Injection Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY AGE
6.1 World Omalizumab Biologic Injection Market Size Overview by Age: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Age
6.2.1 For Adults
6.2.2 For Teenagers
6.2.3 For Children
6.3 Market Segment by Age
6.3.1 World Omalizumab Biologic Injection Market Size by Age (2021-2026)
6.3.2 World Omalizumab Biologic Injection Market Size by Age (2027-2032)
6.3.3 World Omalizumab Biologic Injection Market Size Market Share by Age (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Omalizumab Biologic Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospital
7.2.2 Clinic
7.2.3 Others
7.3 Market Segment by Application
7.3.1 World Omalizumab Biologic Injection Market Size by Application (2021-2026)
7.3.2 World Omalizumab Biologic Injection Market Size by Application (2027-2032)
7.3.3 World Omalizumab Biologic Injection Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Roche
8.1.1 Roche Details
8.1.2 Roche Major Business
8.1.3 Roche Omalizumab Biologic Injection Product and Services
8.1.4 Roche Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Roche Recent Developments/Updates
8.1.6 Roche Competitive Strengths & Weaknesses
8.2 Novartis
8.2.1 Novartis Details
8.2.2 Novartis Major Business
8.2.3 Novartis Omalizumab Biologic Injection Product and Services
8.2.4 Novartis Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Novartis Recent Developments/Updates
8.2.6 Novartis Competitive Strengths & Weaknesses
8.3 Glenmark Pharmaceuticals
8.3.1 Glenmark Pharmaceuticals Details
8.3.2 Glenmark Pharmaceuticals Major Business
8.3.3 Glenmark Pharmaceuticals Omalizumab Biologic Injection Product and Services
8.3.4 Glenmark Pharmaceuticals Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
8.3.6 Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
8.4 Selexis
8.4.1 Selexis Details
8.4.2 Selexis Major Business
8.4.3 Selexis Omalizumab Biologic Injection Product and Services
8.4.4 Selexis Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 Selexis Recent Developments/Updates
8.4.6 Selexis Competitive Strengths & Weaknesses
8.5 Generium
8.5.1 Generium Details
8.5.2 Generium Major Business
8.5.3 Generium Omalizumab Biologic Injection Product and Services
8.5.4 Generium Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Generium Recent Developments/Updates
8.5.6 Generium Competitive Strengths & Weaknesses
8.6 CuraTeQ
8.6.1 CuraTeQ Details
8.6.2 CuraTeQ Major Business
8.6.3 CuraTeQ Omalizumab Biologic Injection Product and Services
8.6.4 CuraTeQ Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 CuraTeQ Recent Developments/Updates
8.6.6 CuraTeQ Competitive Strengths & Weaknesses
8.7 Celltrion Healthcare
8.7.1 Celltrion Healthcare Details
8.7.2 Celltrion Healthcare Major Business
8.7.3 Celltrion Healthcare Omalizumab Biologic Injection Product and Services
8.7.4 Celltrion Healthcare Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Celltrion Healthcare Recent Developments/Updates
8.7.6 Celltrion Healthcare Competitive Strengths & Weaknesses
8.8 Alvotech
8.8.1 Alvotech Details
8.8.2 Alvotech Major Business
8.8.3 Alvotech Omalizumab Biologic Injection Product and Services
8.8.4 Alvotech Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Alvotech Recent Developments/Updates
8.8.6 Alvotech Competitive Strengths & Weaknesses
8.9 BiosanaPharma
8.9.1 BiosanaPharma Details
8.9.2 BiosanaPharma Major Business
8.9.3 BiosanaPharma Omalizumab Biologic Injection Product and Services
8.9.4 BiosanaPharma Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 BiosanaPharma Recent Developments/Updates
8.9.6 BiosanaPharma Competitive Strengths & Weaknesses
8.10 Mabpharm
8.10.1 Mabpharm Details
8.10.2 Mabpharm Major Business
8.10.3 Mabpharm Omalizumab Biologic Injection Product and Services
8.10.4 Mabpharm Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Mabpharm Recent Developments/Updates
8.10.6 Mabpharm Competitive Strengths & Weaknesses
8.11 CSPC Pharmaceutical Group
8.11.1 CSPC Pharmaceutical Group Details
8.11.2 CSPC Pharmaceutical Group Major Business
8.11.3 CSPC Pharmaceutical Group Omalizumab Biologic Injection Product and Services
8.11.4 CSPC Pharmaceutical Group Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 CSPC Pharmaceutical Group Recent Developments/Updates
8.11.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
8.12 Biomabs
8.12.1 Biomabs Details
8.12.2 Biomabs Major Business
8.12.3 Biomabs Omalizumab Biologic Injection Product and Services
8.12.4 Biomabs Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 Biomabs Recent Developments/Updates
8.12.6 Biomabs Competitive Strengths & Weaknesses
8.13 HisunPharm
8.13.1 HisunPharm Details
8.13.2 HisunPharm Major Business
8.13.3 HisunPharm Omalizumab Biologic Injection Product and Services
8.13.4 HisunPharm Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 HisunPharm Recent Developments/Updates
8.13.6 HisunPharm Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Omalizumab Biologic Injection Industry Chain
9.2 Omalizumab Biologic Injection Upstream Analysis
9.3 Omalizumab Biologic Injection Midstream Analysis
9.4 Omalizumab Biologic Injection Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Omalizumab Biologic Injection Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Omalizumab Biologic Injection Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Omalizumab Biologic Injection Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Omalizumab Biologic Injection Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Omalizumab Biologic Injection Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Omalizumab Biologic Injection Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Omalizumab Biologic Injection Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Omalizumab Biologic Injection Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Omalizumab Biologic Injection Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Omalizumab Biologic Injection Players in 2025
Table 12. World Omalizumab Biologic Injection Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Omalizumab Biologic Injection Company Evaluation Quadrant
Table 14. Head Office of Key Omalizumab Biologic Injection Players
Table 15. Omalizumab Biologic Injection Market: Company Product Type Footprint
Table 16. Omalizumab Biologic Injection Market: Company Product Application Footprint
Table 17. Omalizumab Biologic Injection Mergers & Acquisitions Activity
Table 18. United States VS China Omalizumab Biologic Injection Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Omalizumab Biologic Injection Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Omalizumab Biologic Injection Companies, Headquarters (States, Country)
Table 21. United States Based Companies Omalizumab Biologic Injection Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Omalizumab Biologic Injection Revenue Market Share (2021-2026)
Table 23. China Based Omalizumab Biologic Injection Companies, Headquarters (Province, Country)
Table 24. China Based Companies Omalizumab Biologic Injection Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Omalizumab Biologic Injection Revenue Market Share (2021-2026)
Table 26. Rest of World Based Omalizumab Biologic Injection Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Omalizumab Biologic Injection Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Omalizumab Biologic Injection Revenue Market Share (2021-2026)
Table 29. World Omalizumab Biologic Injection Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Omalizumab Biologic Injection Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Omalizumab Biologic Injection Market Size by Type (2027-2032) & (USD Million)
Table 32. World Omalizumab Biologic Injection Market Size by Age, (USD Million), 2021 & 2025 & 2032
Table 33. World Omalizumab Biologic Injection Market Size Value by Age (2021-2026) & (USD Million)
Table 34. World Omalizumab Biologic Injection Market Size by Age (2027-2032) & (USD Million)
Table 35. World Omalizumab Biologic Injection Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Omalizumab Biologic Injection Market Size by Application (2021-2026) & (USD Million)
Table 37. World Omalizumab Biologic Injection Market Size by Application (2027-2032) & (USD Million)
Table 38. Roche Basic Information, Manufacturing Base and Competitors
Table 39. Roche Major Business
Table 40. Roche Omalizumab Biologic Injection Product and Services
Table 41. Roche Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Roche Recent Developments/Updates
Table 43. Roche Competitive Strengths & Weaknesses
Table 44. Novartis Basic Information, Manufacturing Base and Competitors
Table 45. Novartis Major Business
Table 46. Novartis Omalizumab Biologic Injection Product and Services
Table 47. Novartis Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Novartis Recent Developments/Updates
Table 49. Novartis Competitive Strengths & Weaknesses
Table 50. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 51. Glenmark Pharmaceuticals Major Business
Table 52. Glenmark Pharmaceuticals Omalizumab Biologic Injection Product and Services
Table 53. Glenmark Pharmaceuticals Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Glenmark Pharmaceuticals Recent Developments/Updates
Table 55. Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
Table 56. Selexis Basic Information, Manufacturing Base and Competitors
Table 57. Selexis Major Business
Table 58. Selexis Omalizumab Biologic Injection Product and Services
Table 59. Selexis Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Selexis Recent Developments/Updates
Table 61. Selexis Competitive Strengths & Weaknesses
Table 62. Generium Basic Information, Manufacturing Base and Competitors
Table 63. Generium Major Business
Table 64. Generium Omalizumab Biologic Injection Product and Services
Table 65. Generium Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Generium Recent Developments/Updates
Table 67. Generium Competitive Strengths & Weaknesses
Table 68. CuraTeQ Basic Information, Manufacturing Base and Competitors
Table 69. CuraTeQ Major Business
Table 70. CuraTeQ Omalizumab Biologic Injection Product and Services
Table 71. CuraTeQ Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. CuraTeQ Recent Developments/Updates
Table 73. CuraTeQ Competitive Strengths & Weaknesses
Table 74. Celltrion Healthcare Basic Information, Manufacturing Base and Competitors
Table 75. Celltrion Healthcare Major Business
Table 76. Celltrion Healthcare Omalizumab Biologic Injection Product and Services
Table 77. Celltrion Healthcare Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Celltrion Healthcare Recent Developments/Updates
Table 79. Celltrion Healthcare Competitive Strengths & Weaknesses
Table 80. Alvotech Basic Information, Manufacturing Base and Competitors
Table 81. Alvotech Major Business
Table 82. Alvotech Omalizumab Biologic Injection Product and Services
Table 83. Alvotech Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Alvotech Recent Developments/Updates
Table 85. Alvotech Competitive Strengths & Weaknesses
Table 86. BiosanaPharma Basic Information, Manufacturing Base and Competitors
Table 87. BiosanaPharma Major Business
Table 88. BiosanaPharma Omalizumab Biologic Injection Product and Services
Table 89. BiosanaPharma Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. BiosanaPharma Recent Developments/Updates
Table 91. BiosanaPharma Competitive Strengths & Weaknesses
Table 92. Mabpharm Basic Information, Manufacturing Base and Competitors
Table 93. Mabpharm Major Business
Table 94. Mabpharm Omalizumab Biologic Injection Product and Services
Table 95. Mabpharm Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Mabpharm Recent Developments/Updates
Table 97. Mabpharm Competitive Strengths & Weaknesses
Table 98. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 99. CSPC Pharmaceutical Group Major Business
Table 100. CSPC Pharmaceutical Group Omalizumab Biologic Injection Product and Services
Table 101. CSPC Pharmaceutical Group Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. CSPC Pharmaceutical Group Recent Developments/Updates
Table 103. CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
Table 104. Biomabs Basic Information, Manufacturing Base and Competitors
Table 105. Biomabs Major Business
Table 106. Biomabs Omalizumab Biologic Injection Product and Services
Table 107. Biomabs Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Biomabs Recent Developments/Updates
Table 109. Biomabs Competitive Strengths & Weaknesses
Table 110. HisunPharm Basic Information, Manufacturing Base and Competitors
Table 111. HisunPharm Major Business
Table 112. HisunPharm Omalizumab Biologic Injection Product and Services
Table 113. HisunPharm Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. HisunPharm Recent Developments/Updates
Table 115. HisunPharm Competitive Strengths & Weaknesses
Table 116. Global Key Players of Omalizumab Biologic Injection Upstream (Raw Materials)
Table 117. Global Omalizumab Biologic Injection Typical Customers
Table 1. World Omalizumab Biologic Injection Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Omalizumab Biologic Injection Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Omalizumab Biologic Injection Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Omalizumab Biologic Injection Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Omalizumab Biologic Injection Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Omalizumab Biologic Injection Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Omalizumab Biologic Injection Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Omalizumab Biologic Injection Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Omalizumab Biologic Injection Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Omalizumab Biologic Injection Players in 2025
Table 12. World Omalizumab Biologic Injection Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Omalizumab Biologic Injection Company Evaluation Quadrant
Table 14. Head Office of Key Omalizumab Biologic Injection Players
Table 15. Omalizumab Biologic Injection Market: Company Product Type Footprint
Table 16. Omalizumab Biologic Injection Market: Company Product Application Footprint
Table 17. Omalizumab Biologic Injection Mergers & Acquisitions Activity
Table 18. United States VS China Omalizumab Biologic Injection Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Omalizumab Biologic Injection Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Omalizumab Biologic Injection Companies, Headquarters (States, Country)
Table 21. United States Based Companies Omalizumab Biologic Injection Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Omalizumab Biologic Injection Revenue Market Share (2021-2026)
Table 23. China Based Omalizumab Biologic Injection Companies, Headquarters (Province, Country)
Table 24. China Based Companies Omalizumab Biologic Injection Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Omalizumab Biologic Injection Revenue Market Share (2021-2026)
Table 26. Rest of World Based Omalizumab Biologic Injection Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Omalizumab Biologic Injection Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Omalizumab Biologic Injection Revenue Market Share (2021-2026)
Table 29. World Omalizumab Biologic Injection Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Omalizumab Biologic Injection Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Omalizumab Biologic Injection Market Size by Type (2027-2032) & (USD Million)
Table 32. World Omalizumab Biologic Injection Market Size by Age, (USD Million), 2021 & 2025 & 2032
Table 33. World Omalizumab Biologic Injection Market Size Value by Age (2021-2026) & (USD Million)
Table 34. World Omalizumab Biologic Injection Market Size by Age (2027-2032) & (USD Million)
Table 35. World Omalizumab Biologic Injection Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Omalizumab Biologic Injection Market Size by Application (2021-2026) & (USD Million)
Table 37. World Omalizumab Biologic Injection Market Size by Application (2027-2032) & (USD Million)
Table 38. Roche Basic Information, Manufacturing Base and Competitors
Table 39. Roche Major Business
Table 40. Roche Omalizumab Biologic Injection Product and Services
Table 41. Roche Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Roche Recent Developments/Updates
Table 43. Roche Competitive Strengths & Weaknesses
Table 44. Novartis Basic Information, Manufacturing Base and Competitors
Table 45. Novartis Major Business
Table 46. Novartis Omalizumab Biologic Injection Product and Services
Table 47. Novartis Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Novartis Recent Developments/Updates
Table 49. Novartis Competitive Strengths & Weaknesses
Table 50. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 51. Glenmark Pharmaceuticals Major Business
Table 52. Glenmark Pharmaceuticals Omalizumab Biologic Injection Product and Services
Table 53. Glenmark Pharmaceuticals Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Glenmark Pharmaceuticals Recent Developments/Updates
Table 55. Glenmark Pharmaceuticals Competitive Strengths & Weaknesses
Table 56. Selexis Basic Information, Manufacturing Base and Competitors
Table 57. Selexis Major Business
Table 58. Selexis Omalizumab Biologic Injection Product and Services
Table 59. Selexis Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Selexis Recent Developments/Updates
Table 61. Selexis Competitive Strengths & Weaknesses
Table 62. Generium Basic Information, Manufacturing Base and Competitors
Table 63. Generium Major Business
Table 64. Generium Omalizumab Biologic Injection Product and Services
Table 65. Generium Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Generium Recent Developments/Updates
Table 67. Generium Competitive Strengths & Weaknesses
Table 68. CuraTeQ Basic Information, Manufacturing Base and Competitors
Table 69. CuraTeQ Major Business
Table 70. CuraTeQ Omalizumab Biologic Injection Product and Services
Table 71. CuraTeQ Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. CuraTeQ Recent Developments/Updates
Table 73. CuraTeQ Competitive Strengths & Weaknesses
Table 74. Celltrion Healthcare Basic Information, Manufacturing Base and Competitors
Table 75. Celltrion Healthcare Major Business
Table 76. Celltrion Healthcare Omalizumab Biologic Injection Product and Services
Table 77. Celltrion Healthcare Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Celltrion Healthcare Recent Developments/Updates
Table 79. Celltrion Healthcare Competitive Strengths & Weaknesses
Table 80. Alvotech Basic Information, Manufacturing Base and Competitors
Table 81. Alvotech Major Business
Table 82. Alvotech Omalizumab Biologic Injection Product and Services
Table 83. Alvotech Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Alvotech Recent Developments/Updates
Table 85. Alvotech Competitive Strengths & Weaknesses
Table 86. BiosanaPharma Basic Information, Manufacturing Base and Competitors
Table 87. BiosanaPharma Major Business
Table 88. BiosanaPharma Omalizumab Biologic Injection Product and Services
Table 89. BiosanaPharma Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. BiosanaPharma Recent Developments/Updates
Table 91. BiosanaPharma Competitive Strengths & Weaknesses
Table 92. Mabpharm Basic Information, Manufacturing Base and Competitors
Table 93. Mabpharm Major Business
Table 94. Mabpharm Omalizumab Biologic Injection Product and Services
Table 95. Mabpharm Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Mabpharm Recent Developments/Updates
Table 97. Mabpharm Competitive Strengths & Weaknesses
Table 98. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 99. CSPC Pharmaceutical Group Major Business
Table 100. CSPC Pharmaceutical Group Omalizumab Biologic Injection Product and Services
Table 101. CSPC Pharmaceutical Group Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. CSPC Pharmaceutical Group Recent Developments/Updates
Table 103. CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
Table 104. Biomabs Basic Information, Manufacturing Base and Competitors
Table 105. Biomabs Major Business
Table 106. Biomabs Omalizumab Biologic Injection Product and Services
Table 107. Biomabs Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Biomabs Recent Developments/Updates
Table 109. Biomabs Competitive Strengths & Weaknesses
Table 110. HisunPharm Basic Information, Manufacturing Base and Competitors
Table 111. HisunPharm Major Business
Table 112. HisunPharm Omalizumab Biologic Injection Product and Services
Table 113. HisunPharm Omalizumab Biologic Injection Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. HisunPharm Recent Developments/Updates
Table 115. HisunPharm Competitive Strengths & Weaknesses
Table 116. Global Key Players of Omalizumab Biologic Injection Upstream (Raw Materials)
Table 117. Global Omalizumab Biologic Injection Typical Customers
LIST OF FIGURES
Figure 1. Omalizumab Biologic Injection Picture
Figure 2. World Omalizumab Biologic Injection Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Omalizumab Biologic Injection Total Revenue (2021-2032) & (USD Million)
Figure 4. World Omalizumab Biologic Injection Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Omalizumab Biologic Injection Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 13. Omalizumab Biologic Injection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 16. World Omalizumab Biologic Injection Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 18. China Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 23. India Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Omalizumab Biologic Injection by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Omalizumab Biologic Injection Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Omalizumab Biologic Injection Markets in 2025
Figure 27. United States VS China: Omalizumab Biologic Injection Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Omalizumab Biologic Injection Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Omalizumab Biologic Injection Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Omalizumab Biologic Injection Market Size Market Share by Type in 2025
Figure 31. 150 mg/mL
Figure 32. 75 mg/0.5 mL
Figure 33. World Omalizumab Biologic Injection Market Size Market Share by Type (2021-2032)
Figure 34. World Omalizumab Biologic Injection Market Size by Age, (USD Million), 2021 & 2025 & 2032
Figure 35. World Omalizumab Biologic Injection Market Size Market Share by Age in 2025
Figure 36. For Adults
Figure 37. For Teenagers
Figure 38. For Children
Figure 39. World Omalizumab Biologic Injection Market Size Market Share by Age (2021-2032)
Figure 40. World Omalizumab Biologic Injection Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World Omalizumab Biologic Injection Market Size Market Share by Application in 2025
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Others
Figure 45. World Omalizumab Biologic Injection Market Size Market Share by Application (2021-2032)
Figure 46. Omalizumab Biologic Injection Industrial Chain
Figure 47. Methodology
Figure 48. Research Process and Data Source
Figure 1. Omalizumab Biologic Injection Picture
Figure 2. World Omalizumab Biologic Injection Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Omalizumab Biologic Injection Total Revenue (2021-2032) & (USD Million)
Figure 4. World Omalizumab Biologic Injection Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Omalizumab Biologic Injection Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Omalizumab Biologic Injection Revenue (2021-2032) & (USD Million)
Figure 13. Omalizumab Biologic Injection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 16. World Omalizumab Biologic Injection Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 18. China Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 23. India Omalizumab Biologic Injection Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Omalizumab Biologic Injection by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Omalizumab Biologic Injection Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Omalizumab Biologic Injection Markets in 2025
Figure 27. United States VS China: Omalizumab Biologic Injection Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Omalizumab Biologic Injection Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Omalizumab Biologic Injection Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Omalizumab Biologic Injection Market Size Market Share by Type in 2025
Figure 31. 150 mg/mL
Figure 32. 75 mg/0.5 mL
Figure 33. World Omalizumab Biologic Injection Market Size Market Share by Type (2021-2032)
Figure 34. World Omalizumab Biologic Injection Market Size by Age, (USD Million), 2021 & 2025 & 2032
Figure 35. World Omalizumab Biologic Injection Market Size Market Share by Age in 2025
Figure 36. For Adults
Figure 37. For Teenagers
Figure 38. For Children
Figure 39. World Omalizumab Biologic Injection Market Size Market Share by Age (2021-2032)
Figure 40. World Omalizumab Biologic Injection Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World Omalizumab Biologic Injection Market Size Market Share by Application in 2025
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Others
Figure 45. World Omalizumab Biologic Injection Market Size Market Share by Application (2021-2032)
Figure 46. Omalizumab Biologic Injection Industrial Chain
Figure 47. Methodology
Figure 48. Research Process and Data Source
